HUTCHMED (China) (HCM) Liabilities and Shareholders Equity (2015 - 2025)

HUTCHMED (China) (HCM) has 11 years of Liabilities and Shareholders Equity data on file, last reported at $225.4 million in Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $225.4 million, up 37.53% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 billion (up 373.98% YoY), and the FY2025 annual result was $225.4 million, up 37.53% from the prior year.
• Liabilities and Shareholders Equity fell to $225.4 million in Q4 2025 per HCM's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $1.8 billion in Q2 2025 and troughed at $163786.0 in Q4 2023.
• A 5-year average of $541.9 million and a median of $176.2 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity slumped 99.88% in 2023, then surged 99970.22% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $176.2 million in 2021, then fell by 25.32% to $131.6 million in 2022, then plunged by 99.88% to $163786.0 in 2023, then surged by 99970.22% to $163.9 million in 2024, then soared by 37.53% to $225.4 million in 2025.
• Business Quant data shows HCM's Liabilities and Shareholders Equity at $225.4 million in Q4 2025, $1.8 billion in Q2 2025, and $163.9 million in Q4 2024.